Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights

16 November 2026

This PVRI Digital Webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' session. Features:

  • Use of the plasma proteome for risk stratifying patients with PAH - Christopher J. Rhodes, Imperial College London
  • Validation of biomarkers for clinical use: methological challenges and the path forward - Anna Hemnes, Vanderbilt University
  • NOTCH3-ECD as a Biomarker for PAH - Patricia A. Thistlethwaite, University of California
  • Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension - Mona Alotaibi, University of California San Diego
  • Blood endostatin, a Collagen18a1 fragment, as markers of vascular dysfunction in PAH - Grazyna Kwapiszewska, University of Graz

Moderated by Patricia A. Thistlethwaite - University of California 

This session was run live on 12 November, 16:00 – 17:30 GMT.

Share:

More from PVRI Digital Webinar Series

Show more details

The PVRI Digital Webinar Series enables our worldwide community the opportunity to connect and learn cutting-edge new research. The live webinars are open to everyone to attend and offer ample time for questions to encourage active audience participation. Recordings are uploaded to our website for our members to watch.